Synergistic Inhibition of Drug-Resistant Colon Cancer Growth with PI3K/mTOR Dual Inhibitor BEZ235 and Nano-Emulsioned Paclitaxel via Reducing Multidrug Resistance and Promoting Apoptosis

Yali Hu,1,2,* Kunpeng Zhang,1,* Xingyao Zhu,1,* Xiuyan Zheng,1 Chao Wang,1 Xiao Niu,1 Teng Jiang,1 Xinhua Ji,1 Weilin Zhao,1 Lijuan Pang,1 Yan Qi,1 Feng Li,1,3 Li Li,4 Zhiping Xu,4 Wenyi Gu,4 Hong Zou1 1Department of Pathology, The First Affiliated Hospital, School of Medicine, Shihezi University, K...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hu Y, Zhang K, Zhu X, Zheng X, Wang C, Niu X, Jiang T, Ji X, Zhao W, Pang L, Qi Y, Li F, Li L, Xu Z, Gu W, Zou H
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/f243e3f03cd7469f9deb1c4c0d27bb34
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f243e3f03cd7469f9deb1c4c0d27bb34
record_format dspace
spelling oai:doaj.org-article:f243e3f03cd7469f9deb1c4c0d27bb342021-12-02T13:28:24ZSynergistic Inhibition of Drug-Resistant Colon Cancer Growth with PI3K/mTOR Dual Inhibitor BEZ235 and Nano-Emulsioned Paclitaxel via Reducing Multidrug Resistance and Promoting Apoptosis1178-2013https://doaj.org/article/f243e3f03cd7469f9deb1c4c0d27bb342021-03-01T00:00:00Zhttps://www.dovepress.com/synergistic-inhibition-of-drug-resistant-colon-cancer-growth-with-pi3k-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Yali Hu,1,2,* Kunpeng Zhang,1,* Xingyao Zhu,1,* Xiuyan Zheng,1 Chao Wang,1 Xiao Niu,1 Teng Jiang,1 Xinhua Ji,1 Weilin Zhao,1 Lijuan Pang,1 Yan Qi,1 Feng Li,1,3 Li Li,4 Zhiping Xu,4 Wenyi Gu,4 Hong Zou1 1Department of Pathology, The First Affiliated Hospital, School of Medicine, Shihezi University, Key Laboratory of Xinjiang Endemic and Ethnic Diseases of the Ministry of Education of China, Xinjiang, 832002, People’s Republic of China; 2Department of Oncology, Yongcheng People’s Hospital, Henan, 476600, People’s Republic of China; 3Department of Pathology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, 10000, People’s Republic of China; 4Australian Institute of Bioengineering and Nanotechnology, University of Queensland, Queensland, 4072, Australia*These authors contributed equally to this workCorrespondence: Hong Zou; Wenyi Gu Tel +86 13899528366; +61733464168Email zouhong_patho@163.com; w.gu@uq.edu.auBackground: Colon cancer is a top lethal cancer in man and women worldwide and drug resistance is the major cause of cancer-related death. Combinational therapy and drug delivery with nanoparticles have been shown to effectively overcome drug resistance in many cancers. We previously reported that nanoemulsion (NE) loaded paclitaxel (PTX) and BEZ235 could synergistically inhibit colon cancer cell growth.Purpose: To investigate whether NE loaded PTX and BEZ235 can overcome drug resistance and synergistically inhibit drug-resistant colon cancer cell growth in vitro and in vivo.Methods: The in vitro treatment effect on cell viability was assayed using CCK8 kit, cell morphological change was detected by β-tubulin immunofluorescence staining, drug resistance-related proteins were analyzed by Western blotting, and in vivo tumor growth test was performed in nude mice xeno-transplanted with 2 drug-resistant colon cancer cell lines HCT116-LOHP and HT29-DDP.Results: Both cell lines were sensitive to PTX but relatively insensitive to BEZ235. PTX combined with BEZ235 synergistically inhibited the proliferation of both cell lines. Nanoemulsion loaded PTX (NE-PTX) reduced the IC50 of PTX to approximately 2/5 of free PTX, indicating a high inhibitory efficacy of NE-PTX. When NE-PTX combined with a low concentration of BEZ235 (50 nM), the IC50 was decreased to approximately 2/3 of free PTX. Moreover, NE-PTX+BEZ235 treatment increased apoptosis, decreased Pgp and ABCC1 expression, and reduced tumor weights compared to the single drug treatment and the control group. These results suggest that nanoemulsion loaded PTX+BEZ235 can overcome drug resistance and improve the inhibitory effect on cancer cell proliferation and tumor growth.Conclusion: Our study thus provides a possible new approach to treat colon cancer patients with drug resistance.Keywords: colon cancer, nanoemulsion, paclitaxel, BEZ235, drug-resistanceHu YZhang KZhu XZheng XWang CNiu XJiang TJi XZhao WPang LQi YLi FLi LXu ZGu WZou HDove Medical Pressarticlecolon cancernanoemulsionpaclitaxelbez235drug-resistance.Medicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 16, Pp 2173-2186 (2021)
institution DOAJ
collection DOAJ
language EN
topic colon cancer
nanoemulsion
paclitaxel
bez235
drug-resistance.
Medicine (General)
R5-920
spellingShingle colon cancer
nanoemulsion
paclitaxel
bez235
drug-resistance.
Medicine (General)
R5-920
Hu Y
Zhang K
Zhu X
Zheng X
Wang C
Niu X
Jiang T
Ji X
Zhao W
Pang L
Qi Y
Li F
Li L
Xu Z
Gu W
Zou H
Synergistic Inhibition of Drug-Resistant Colon Cancer Growth with PI3K/mTOR Dual Inhibitor BEZ235 and Nano-Emulsioned Paclitaxel via Reducing Multidrug Resistance and Promoting Apoptosis
description Yali Hu,1,2,* Kunpeng Zhang,1,* Xingyao Zhu,1,* Xiuyan Zheng,1 Chao Wang,1 Xiao Niu,1 Teng Jiang,1 Xinhua Ji,1 Weilin Zhao,1 Lijuan Pang,1 Yan Qi,1 Feng Li,1,3 Li Li,4 Zhiping Xu,4 Wenyi Gu,4 Hong Zou1 1Department of Pathology, The First Affiliated Hospital, School of Medicine, Shihezi University, Key Laboratory of Xinjiang Endemic and Ethnic Diseases of the Ministry of Education of China, Xinjiang, 832002, People’s Republic of China; 2Department of Oncology, Yongcheng People’s Hospital, Henan, 476600, People’s Republic of China; 3Department of Pathology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, 10000, People’s Republic of China; 4Australian Institute of Bioengineering and Nanotechnology, University of Queensland, Queensland, 4072, Australia*These authors contributed equally to this workCorrespondence: Hong Zou; Wenyi Gu Tel +86 13899528366; +61733464168Email zouhong_patho@163.com; w.gu@uq.edu.auBackground: Colon cancer is a top lethal cancer in man and women worldwide and drug resistance is the major cause of cancer-related death. Combinational therapy and drug delivery with nanoparticles have been shown to effectively overcome drug resistance in many cancers. We previously reported that nanoemulsion (NE) loaded paclitaxel (PTX) and BEZ235 could synergistically inhibit colon cancer cell growth.Purpose: To investigate whether NE loaded PTX and BEZ235 can overcome drug resistance and synergistically inhibit drug-resistant colon cancer cell growth in vitro and in vivo.Methods: The in vitro treatment effect on cell viability was assayed using CCK8 kit, cell morphological change was detected by β-tubulin immunofluorescence staining, drug resistance-related proteins were analyzed by Western blotting, and in vivo tumor growth test was performed in nude mice xeno-transplanted with 2 drug-resistant colon cancer cell lines HCT116-LOHP and HT29-DDP.Results: Both cell lines were sensitive to PTX but relatively insensitive to BEZ235. PTX combined with BEZ235 synergistically inhibited the proliferation of both cell lines. Nanoemulsion loaded PTX (NE-PTX) reduced the IC50 of PTX to approximately 2/5 of free PTX, indicating a high inhibitory efficacy of NE-PTX. When NE-PTX combined with a low concentration of BEZ235 (50 nM), the IC50 was decreased to approximately 2/3 of free PTX. Moreover, NE-PTX+BEZ235 treatment increased apoptosis, decreased Pgp and ABCC1 expression, and reduced tumor weights compared to the single drug treatment and the control group. These results suggest that nanoemulsion loaded PTX+BEZ235 can overcome drug resistance and improve the inhibitory effect on cancer cell proliferation and tumor growth.Conclusion: Our study thus provides a possible new approach to treat colon cancer patients with drug resistance.Keywords: colon cancer, nanoemulsion, paclitaxel, BEZ235, drug-resistance
format article
author Hu Y
Zhang K
Zhu X
Zheng X
Wang C
Niu X
Jiang T
Ji X
Zhao W
Pang L
Qi Y
Li F
Li L
Xu Z
Gu W
Zou H
author_facet Hu Y
Zhang K
Zhu X
Zheng X
Wang C
Niu X
Jiang T
Ji X
Zhao W
Pang L
Qi Y
Li F
Li L
Xu Z
Gu W
Zou H
author_sort Hu Y
title Synergistic Inhibition of Drug-Resistant Colon Cancer Growth with PI3K/mTOR Dual Inhibitor BEZ235 and Nano-Emulsioned Paclitaxel via Reducing Multidrug Resistance and Promoting Apoptosis
title_short Synergistic Inhibition of Drug-Resistant Colon Cancer Growth with PI3K/mTOR Dual Inhibitor BEZ235 and Nano-Emulsioned Paclitaxel via Reducing Multidrug Resistance and Promoting Apoptosis
title_full Synergistic Inhibition of Drug-Resistant Colon Cancer Growth with PI3K/mTOR Dual Inhibitor BEZ235 and Nano-Emulsioned Paclitaxel via Reducing Multidrug Resistance and Promoting Apoptosis
title_fullStr Synergistic Inhibition of Drug-Resistant Colon Cancer Growth with PI3K/mTOR Dual Inhibitor BEZ235 and Nano-Emulsioned Paclitaxel via Reducing Multidrug Resistance and Promoting Apoptosis
title_full_unstemmed Synergistic Inhibition of Drug-Resistant Colon Cancer Growth with PI3K/mTOR Dual Inhibitor BEZ235 and Nano-Emulsioned Paclitaxel via Reducing Multidrug Resistance and Promoting Apoptosis
title_sort synergistic inhibition of drug-resistant colon cancer growth with pi3k/mtor dual inhibitor bez235 and nano-emulsioned paclitaxel via reducing multidrug resistance and promoting apoptosis
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/f243e3f03cd7469f9deb1c4c0d27bb34
work_keys_str_mv AT huy synergisticinhibitionofdrugresistantcoloncancergrowthwithpi3kmtordualinhibitorbez235andnanoemulsionedpaclitaxelviareducingmultidrugresistanceandpromotingapoptosis
AT zhangk synergisticinhibitionofdrugresistantcoloncancergrowthwithpi3kmtordualinhibitorbez235andnanoemulsionedpaclitaxelviareducingmultidrugresistanceandpromotingapoptosis
AT zhux synergisticinhibitionofdrugresistantcoloncancergrowthwithpi3kmtordualinhibitorbez235andnanoemulsionedpaclitaxelviareducingmultidrugresistanceandpromotingapoptosis
AT zhengx synergisticinhibitionofdrugresistantcoloncancergrowthwithpi3kmtordualinhibitorbez235andnanoemulsionedpaclitaxelviareducingmultidrugresistanceandpromotingapoptosis
AT wangc synergisticinhibitionofdrugresistantcoloncancergrowthwithpi3kmtordualinhibitorbez235andnanoemulsionedpaclitaxelviareducingmultidrugresistanceandpromotingapoptosis
AT niux synergisticinhibitionofdrugresistantcoloncancergrowthwithpi3kmtordualinhibitorbez235andnanoemulsionedpaclitaxelviareducingmultidrugresistanceandpromotingapoptosis
AT jiangt synergisticinhibitionofdrugresistantcoloncancergrowthwithpi3kmtordualinhibitorbez235andnanoemulsionedpaclitaxelviareducingmultidrugresistanceandpromotingapoptosis
AT jix synergisticinhibitionofdrugresistantcoloncancergrowthwithpi3kmtordualinhibitorbez235andnanoemulsionedpaclitaxelviareducingmultidrugresistanceandpromotingapoptosis
AT zhaow synergisticinhibitionofdrugresistantcoloncancergrowthwithpi3kmtordualinhibitorbez235andnanoemulsionedpaclitaxelviareducingmultidrugresistanceandpromotingapoptosis
AT pangl synergisticinhibitionofdrugresistantcoloncancergrowthwithpi3kmtordualinhibitorbez235andnanoemulsionedpaclitaxelviareducingmultidrugresistanceandpromotingapoptosis
AT qiy synergisticinhibitionofdrugresistantcoloncancergrowthwithpi3kmtordualinhibitorbez235andnanoemulsionedpaclitaxelviareducingmultidrugresistanceandpromotingapoptosis
AT lif synergisticinhibitionofdrugresistantcoloncancergrowthwithpi3kmtordualinhibitorbez235andnanoemulsionedpaclitaxelviareducingmultidrugresistanceandpromotingapoptosis
AT lil synergisticinhibitionofdrugresistantcoloncancergrowthwithpi3kmtordualinhibitorbez235andnanoemulsionedpaclitaxelviareducingmultidrugresistanceandpromotingapoptosis
AT xuz synergisticinhibitionofdrugresistantcoloncancergrowthwithpi3kmtordualinhibitorbez235andnanoemulsionedpaclitaxelviareducingmultidrugresistanceandpromotingapoptosis
AT guw synergisticinhibitionofdrugresistantcoloncancergrowthwithpi3kmtordualinhibitorbez235andnanoemulsionedpaclitaxelviareducingmultidrugresistanceandpromotingapoptosis
AT zouh synergisticinhibitionofdrugresistantcoloncancergrowthwithpi3kmtordualinhibitorbez235andnanoemulsionedpaclitaxelviareducingmultidrugresistanceandpromotingapoptosis
_version_ 1718393009401233408